Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rusfertide in Phlebotomy-Requiring Polycythemia Vera
NCT04057040Phase 2Completed
- Sponsor
- Protagonist Therapeutics, Inc.
- Start
- Oct 2019
- Primary completion
- Feb 2023
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of rusfertide in polycythemia vera (PV), sponsored by Protagonist Therapeutics, Inc.. Started Oct 2019; status: completed.
02
Drugs
rusfertide
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT04057040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04057040.